After a year of big advances, AstraZeneca CEO Pascal Soriot takes home a major-league pay package
By all accounts, 2019 was a great year for AstraZeneca — and it paid off for CEO Pascal Soriot with a big boost in his annual compensation package.
According to the pharma giant’s latest annual report, Soriot bagged a compensation package worth £14.3 million — $18.5 million if you count that in dollars. While his base pay ticked up only slightly, Soriot took home an upsized batch of longterm incentives valued at £10.5 million for 2019 — which compares to total pay valued at £10.4 million in 2017.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 157,500+ biopharma pros reading Endpoints daily — and it's free.